Detail
| LncRNA Name | LINC02163 |
| Synonyms | NA |
| Region | GRCh38_5:104079911-104105,403 Sequence |
| Ensembl | ENSG00000251026 |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot, etc. |
| Sample | Gastric cancer cell lines, normal gastric epithelial cell line. |
| Expression Pattern | up-regulated |
| Function Description | To the best of our knowledge, our findings provided the first evidence that LINC02163 functioned as an oncogene in GC. LINC02163 may be a candidate prognostic biomarker and a target for new therapies in GC patients.GC patients with high LINC02163 expression had shorter disease-free survival and the over-all survival rate than those with low LINC02163 expression.The miR-593-3p/FOXK1 axis mediated LINC02163â??s effect on GC. |
| Pubmed ID | 29893595 |
| Year | 2018 |
| Title | LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells. |
| External Links |
| Links for LINC02163 | GenBank HGNC lncrnadb Noncode |
| Links for gastric cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.